SIGHT SCIENCES, INC. (SGHT) Current Ratio
- Current ratio · latest quarter: Value 4.95×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.95× | Current assets / current liabilities. $101.44M ÷ $20.50M ≈ 4.95× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 101.44M USD | Assets, Current |
| Current obligations | 20.50M USD | Liabilities, Current |
| Cash and equivalents | 79.75M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 11.39M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 5.70M USD | Inventory, Net |
| Payables | 1.90M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 10.13M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $101.44M | $20.50M | $79.75M | (m) | $11.39M | $5.70M | $1.90M | $10.13M | 4.95× |
| 2026-03-31 | $106.51M | $18.16M | $84.96M | (m) | $10.60M | $7.01M | $1.49M | $3.80M | 5.86× |
| 2025-12-31 | $112.73M | $11.03M | $91.97M | (m) | $9.74M | $7.77M | $1.34M | $0.00 | 10.22× |
| 2025-09-30 | $113.59M | $11.83M | $92.37M | (m) | $9.74M | $7.98M | $1.74M | $0.00 | 9.60× |
| 2025-06-30 | $119.43M | $11.94M | $101.50M | (m) | $9.61M | $6.21M | $2.08M | $0.00 | 10.01× |
| 2025-03-31 | $126.91M | $12.12M | $108.77M | (m) | $9.42M | $5.80M | $2.77M | $0.00 | 10.47× |
| 2024-12-31 | $139.77M | $15.47M | $120.36M | (m) | $10.79M | $6.33M | $1.69M | $0.00 | 9.04× |
| 2024-09-30 | $140.47M | $13.80M | $118.56M | (m) | $12.93M | $6.09M | $1.30M | $0.00 | 10.18× |
| 2024-06-30 | $146.33M | $13.29M | $118.18M | (m) | $19.92M | $6.78M | $1.92M | $0.00 | 11.01× |
| 2024-03-31 | $152.09M | $11.69M | $127.28M | (m) | $15.64M | $6.87M | $1.67M | $0.00 | 13.01× |
| 2023-12-31 | $162.87M | $12.25M | $138.13M | (m) | $14.29M | $7.85M | $1.73M | $2.22M | 13.29× |
| 2023-09-30 | $173.56M | $14.33M | $144.50M | (m) | $16.92M | $9.24M | $3.54M | $0.00 | 12.11× |
| 2023-06-30 | $182.32M | $14.05M | $154.51M | (m) | $18.10M | $7.91M | $2.95M | $0.00 | 12.97× |
| 2023-03-31 | $193.65M | $15.14M | $167.34M | (m) | $16.36M | $7.14M | $3.50M | $0.00 | 12.79× |
| 2022-12-31 | $209.68M | $17.82M | $185.00M | (m) | $15.15M | $6.11M | $2.69M | $0.00 | 11.77× |
| 2022-09-30 | $222.34M | $17.39M | $199.82M | (m) | $12.59M | $5.52M | $3.24M | $0.00 | 12.79× |
| 2022-06-30 | $237.55M | $14.20M | $220.10M | (m) | $10.47M | $4.94M | $2.73M | $0.00 | 16.73× |
| 2022-03-31 | $255.31M | $12.00M | $238.59M | (m) | $9.95M | $4.08M | $3.07M | $0.00 | 21.28× |
| 2021-12-31 | $277.04M | $13.50M | $260.69M | (m) | $8.71M | $3.48M | $3.35M | $0.00 | 20.52× |
| 2021-09-30 | $287.84M | $10.31M | $271.48M | (m) | $8.92M | $2.95M | $1.84M | $0.00 | 27.90× |
| 2021-06-30 | $47.39M | $12.06M | $35.57M | (m) | $6.89M | $2.58M | $3.22M | $0.00 | 3.93× |
| 2020-12-31 | $70.63M | $9.31M | $61.51M | (m) | $5.36M | $2.60M | $2.16M | $0.00 | 7.58× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |